AzTrials
AzTrials

Breast Cancer SurvivorsNCT05386628

The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors

A study testing conventional physiotherapy, Manual lymphatic drainage and Myofascial relasing in people with Breast Cancer Survivors, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In breast cancer patients, limitation of shoulder joint movement occurs following mastectomy surgery. Studies have reported that damage to the fascia on the pectoralis major muscle during mastectomy surgery contributes to the development of the limitation. Read more about this study

Who is it for?
Ages 30 to 60 years, women only
Conditions the study is for
Breast Cancer Survivors
What is being tested?
conventional physiotherapy, Manual lymphatic drainage and Myofascial relasing
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Aug 2022to 1 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women between the ages of 30-60
  • Having breast surgery within 2 years
  • Not have received conservative treatment for shoulder rehabilitation in the last 6 months
  • Having limitation of movement of the shoulder joint due to breast surgery

Who cannot join

  • Not having agreed to participate in the study
  • Having undergone radical mastectomy surgery
  • Having connective tissue disease
  • Presence of brachial plexus paresis/plegia
  • Presence of radiogenic fibrosis
  • Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions
Show all 13Show fewer
  • Presence of active metastases
  • Having undergone reconstruction surgery
  • Continuation of radiotherapy (must have ended at least 3 months ago) or chemotherapy applications
  • Having had a bilateral mastectomy
  • To develop lymphedema in the arm-trunk
  • Use of muscle relaxants
  • Patients with severe chemotherapy side effects (hyperesthesia, nausea, skin changes, weakness, etc.)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • İstanbul Medeniyet University

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion Following Mastectomy Surgery in Breast Cancer Survivors

In breast cancer patients, limitation of shoulder joint movement occurs following mastectomy surgery. Studies have reported that damage to the fascia on the pectoralis major muscle during mastectomy surgery contributes to the development of the limitation. The aim of this study is to investigate the effect of release techniques applied to the fascia on the pectoralis major muscle and the fascial chain on the incerasing of shoulder joint range of motion.

Read the detailed description

After mastectomy, complications such as decreased range of motion and muscle strength in the shoulder joint, development of pain and tenderness, and formation of lymphedema are frequently observed. In addition to causing a significant decrease in the patient's daily life quality, shoulder limitation also negatively affects the treatment process by preventing the joint position required for radiotherapy. For this reason, it is a priority to prevent the development of shoulder joint limitations that may occur following surgery and to open the developing limitation immediately. This study was born from the idea that the relaxation techniques to be applied to regain the mobility of the fascial structure, which has been damaged and whose mobility has decreased due to breast surgery, should be performed by covering the entire myofascial chain. In addition, the investigators aim to prevent adhesions that will limit the mobility of soft tissue by minimizing scar tissue formation with early drainage of postoperative edema. The aim of this study is to investigate the effectiveness of myofascial chain relaxation techniques and manual lymphatic drainage applied to improve soft tissue mobility in the prevention and elimination of shoulder limitations after breast cancer surgery.

A total of 48 patients who agreed to participate in the study will be enrolled in the treatment program twice a week for 6 weeks. During the study, the same assessments will be applied to all patients and the cases will be evaluated 3 times (pre-treatment, post treatment, and one month post treatment). During the assessments, the physical evaluations of the patients on the shoulder region will be examined in detail using objective and subjective methods.

Being tested
conventional physiotherapy, Manual lymphatic drainage, Myofascial relasing
Keywords
breast cancer, range of motion, lymphatic drainage
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • conventional physiotherapyOther

    A basic physiotherapy program consisting of shoulder exercises will be applied to the participants.

    content of the physiotherapy program

    • Shoulder passive/active abduction, flexion, internal and external rotation exercises
    • Posture exercises
    • Neck stretching exercises
    • Pectoralis major stretching exercises
    • Shoulder capsule stretching exercises
    • Scapular Mobilization exercises
  • Manual lymphatic drainageOther

    manual lymph drainage is a manual technique that is applied to the lymphatic system with a pressure of 40-50 mmHg and increases the working speed of lymphatic nodules/collectors. Manual lymph drainage will be made to the anterior axillar-axillar, posterior axillar-axillar and axilla-inguinal anastomosis collectors and the arm region (up to the elbow) lymph collectors.

  • Myofascial relasingOther

    it will be done with the thumb or 3rd finger from the acu points of the superficial arm-anterior myofascial chain. 6-8 seconds with thumb to these points. pressure will be applied and vibration will be given clockwise.

Study groups in NCT05386628
Study groupRoleWhat they receive
control groupActive comparatorConventional physiotherapy program (joint movement exercises, local relaxation techniques, etc.) will be applied to the participants in this group.
Receives: Other: conventional physiotherapy
Manual lymphatic drainage groupExperimentalIn addition to the conventional physiotherapy program, manual lymphatic drainage (including upper limb extremity and anterior/posterior axillar-axillar anastomoses and axilla-inguinal anastomosis) will be applied to the participants in this group.
Receives: Other: conventional physiotherapy; Other: Manual lymphatic drainage
Myofascial relasing groupExperimentalIn addition to the conventional physiotherapy program, myofascial chain relasing techniques will be applied to the participants in this group.
Receives: Other: conventional physiotherapy; Other: Myofascial relasing
Lymphatic drainage and myofascial releasing groupExperimentalIn addition to the conventional physiotherapy program, manual lymphatic drainage (including upper limb extremity and anterior/posterior axillar-axillar anastomoses and axilla-inguinal anastomosis) and myofascial chain relasing techniques will be applied to the participants in this group.
Receives: Other: conventional physiotherapy; Other: Manual lymphatic drainage; Other: Myofascial relasing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measurement of tissue stiffness (N/m)

    Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain .

    Measured: changes from baseline stiffness values will be measured at 6 week and 10 week

  2. measurement of passive muscle tone (Hz)

    muscle tones will be measured with myotonPro on centers of coordination located along the myofascial chain

    Measured: changes from baseline tone values will be measured at 6 week and 10 week

  3. measurement of creep of tissue

    creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

    Measured: changes from baseline creep values will be measured at 6 week and 10 week

  4. measurement of the range of shoulder joint motion

    The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

    Measured: changes from baseline range of the shoulder joint motion values will be measured at 6 week and 10 week

  5. assessment of activity of daily living

    upper extremity daily living functional capacity of participation will be assessed with the Quick-DASH (Shortened Disabilities Arm, Shoulder and Hand Questionnaire). The scale consists of 11 items. In the scale, a 5-point Likert scale is evaluated and scored 1-5. The scores that can be obtained from the scale are between 0-100. Lower scores indicate better daily activity participation.

    Measured: changes from baseline Quick-DASH Questionnaire scores will be assessment at 6 week and 10 week

  6. assessment of depression and anxiety

    quality of life will be assessed using the Hospital Anxiety and Depression Scale (HAD). The scale consists of 14 items (7 items depression and 7 items anxiety). The scale is evaluated on a 4-point Likert scale and is scored 0-3. Depression and anxiety scores are calculated separately. While the score range that can be taken in the lower scales is 0-21, low scores are considered positive.

    Measured: changes from baseline HAD scale scores will be assessment at 6 week and 10 week

Secondary outcomes (4)
  1. measurement of skin temperature

    measurements will be taken from the area covering 3 cm of the surgical incision with a P45 thermographic camera with high thermal sensitivity (Flir Sistem, ThermaCAM, Sweden).

    Measured: changes from baseline skin temperature values will be measured at 6 week and 10 week

  2. measurement of pain

    Pain will be evaluated by visual analog scale (VAS). In the scale, the patient is asked to mark the most appropriate pain intensity on a scale ranging from 0 (no pain) to 10 (tolerable pain). The higher the score, the greater the pain intensity.

    Measured: changes from baseline pain values will be measured at 6 week and 10 week

  3. measurement of pain pressure threshold

    Pain pressure threshold will be evaluated by a digital algometer (Algometer Commander, Jtech Medical, MM036_K, 2016).

    Measured: changes from baseline pain pressure threshold values will be measured at 6 week and 10 week

  4. measurement of grip strength

    The grip strength of both hand will be evaluated by "hand-held" dynamometer.

    Measured: changes from baseline grip strength values will be measured at 6 week and 10 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2022
  2. Study start15 Aug 2022
  3. Primary completion15 Jan 2025
  4. Study completion1 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05386628
Sponsor's protocol ID
2022/0132
Status last verified
Jul 2026
First submitted
18 May 2022
Last updated
3 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing conventional physiotherapy, Manual lymphatic drainage and Myofascial relasing in people with Breast Cancer Survivors, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measurement of tissue stiffness (N/m) (time frame: changes from baseline stiffness values will be measured at 6 week and 10 week). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in